Identification of substance use and dependence among patients with viral hepatitis

Digestive and Liver Disease

Volumn 42, Issue 9, 2010, Pages 650-656

  Jackson, Colin B ^a   Varon, Jack ^a   Ho, Ann ^a   Marks, Kristen M ^b   Talal, Andrew H ^b   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Co dependency; Cocaine; Hepatitis C HIV co infection; Heroin; Self administered scales

Indexed keywords

ILLICIT DRUG;

ADULT; AGED; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ARTICLE; COCAINE DEPENDENCE; DRUG DEPENDENCE; FEMALE; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; VIRUS HEPATITIS;

EID: 77955282466     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.03.002     Document Type: Article

References (38)

1. World Health Organization. Hepatitis C. Fact Sheet No. 164. Available at: ; 2000 [accessed 15.07.09]. http://www.who.int/mediacentre/factsheets/fs164/en/.
2. Armstrong G.L., Wasley A., Simard E.P., et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006, 144:705-714.
3. Wasley A., Miller J.T., Finelli L. Surveillance for acute viral hepatitis-United States, 2005. MMWR Surveill Summ 2007, 56:1-24.
4. Martinez A., Talal A.H. Noninjection drug use: an under-appreciated risk factor for hepatitis C virus transmission. Liver Int 2008, 28:757-760.
5. Kreek M.J., Talal A.H., Piccolo P. Treating chronic hepatitis C in recovering opiate addicts: yes, we can. Dig Liver Dis 2009, 41:308-310.
6. Ghany M.G., Strader D.B., Thomas D.L., et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009, 49:1335-1374.
7. Grebely J., Raffa J.D., Lai C., et al. Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents. J Viral Hepat 2009, 16:352-358.
8. Mehta S.H., Genberg B.L., Astemborski J., et al. Limited uptake of hepatitis C treatment among injection drug users. J Community Health 2008, 33:126-133.
9. Sylvestre D.L. Treating hepatitis C in methadone maintenance patients: an interim analysis. Drug Alcohol Depend 2002, 67:117-123.
10. Litwin A.H., Harris K.A., Nahvi S., et al. Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. J Subst Abuse Treat 2009, 37:32-40.
11. Link B.G., Struening E.L., Rahav M., et al. On stigma and its consequences: evidence from a longitudinal study of men with dual diagnoses of mental illness and substance abuse. J Health Soc Behav 1997, 38:177-190.
12. Friedmann P.D., McCullough D., Saitz R. Screening and intervention for illicit drug abuse: a national survey of primary care physicians and psychiatrists. Arch Intern Med 2001, 161:248-251.
13. Millstein S.G., Marcell A.V. Screening and counseling for adolescent alcohol use among primary care physicians in the United States. Pediatrics 2003, 111:114-122.
14. D'Amico E.J., Paddock S.M., Burnam A., et al. Identification of and guidance for problem drinking by general medical providers: results from a national survey. Med Care 2005, 43:229-236.
15. Fishbein D.A., Lo Y., Reinus J.F., et al. Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection. J Acquir Immune Defic Syndr 2004, 37:1367-1375.
16. Deitz D., Rohde F. Prevalence of screening for alcohol use by physicians during routine physical examinations. Alcohol Health & Research World 1994, 18:162-168.
17. Brown R.L., Leonard T., Saunders L.A., et al. A two-item conjoint screen for alcohol and other drug problems. J Am Board Fam Pract 2001, 14:95-106.
18. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC. 4th ed. (revised ed.).
19. Kellogg S.H., McHugh P.F., Bell K., et al. The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications. Drug Alcohol Depend 2003, 69:137-150.
20. Gitto S., Micco L., Conti F., et al. Alcohol and viral hepatitis: a mini-review. Dig Liver Dis 2009, 41:67-70.
21. Beck A.T., Steer R.A., Brown G.K. Beck Depression Inventory Manual 1996, Psychological Corp, New York. 2nd edition.
22. Dore G.J., Hellard M., Matthews G., et al. Effective treatment of injecting drug users with recently acquired Hepatitis C virus infection. Gastroenterology 2009.
23. Scheuer P.J. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991, 13:372-374.
24. Torbenson M., Thomas D.L. Occult hepatitis B. Lancet Infect Dis 2002, 2:479-486.
25. Novick D.M., Trigg H.L., Des Jarlais D.C., et al. Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City. J Med Virol 1989, 29:181-185.
26. Leri F., Tremblay A., Sorge R.E., et al. Methadone maintenance reduces heroin- and cocaine-induced relapse without affecting stress-induced relapse in a rodent model of poly-drug use. Neuropsychopharmacology 2004, 29:1312-1320.
27. Kosten T.R., Rounsaville B.J., Kleber H.D. A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Arch Gen Psychiatry 1986, 43:733-738.
28. Leri F., Zhou Y., Goddard B., et al. Steady-state methadone blocks cocaine seeking and cocaine-induced gene expression alterations in the rat brain. Eur Neuropsychopharmacol 2009, 19:238-249.
29. Schluger J.H., Borg L., Ho A., et al. Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction. Neuropsychopharmacology 2001, 24:568-575.
30. National Institute of Drug Abuse Principles of Drug Addiction Treatment: A Research-Based Guide 2009, National Institute of Drug Abuse, Bethesda, NIH publication No 09-4180. 2nd ed.
31. Backmund M., Meyer K., Von Zielonka M., et al. Treatment of hepatitis C infection in injection drug users. Hepatology 2001, 34:188-193.
32. Schaefer M., Heinz A., Backmund M. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?. Addiction 2004, 99:1167-1175.
33. Sylvestre D.L., Clements B.J. Adherence to hepatitis C treatment in recovering heroin users maintained on methadone. Eur J Gastroenterol Hepatol 2007, 19:741-747.
34. McHutchison J.G., Manns M., Patel K., et al. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 2002, 123:1061-1069.
35. West R., McNeill A., Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 2000, 55:987-999.
36. Novick D.M., Ochshorn M., Ghali V., et al. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J Pharmacol Exp Ther 1989, 250:606-610.
37. Ochshorn-Adelson M., Bodner G., Toraker P., et al. Effects of ethanol on human natural killer cell activity: in vitro and acute, low-dose in vivo studies. Alcohol Clin Exp Res 1994, 18:1361-1367.
38. Pessione F., Degos F., Marcellin P., et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 1998, 27:1717-1722.